Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the preference of Calcichew D3 500/400 (containing
500 mg calcium and 400 IU of vitamin D) with Adcal-D3 600/400 (containing 600 mg of calcium
and 400 IU of vitamin D) in Test Group 1, and to compare Calcichew D3 500/800 (containing 500
mg calcium and 800 IU vitamin D) with Kalcipos-D 500/800 (containing 500 mg of calcium and
800 IU of vitamin D) in Test Group 2.
Phase:
Phase 4
Details
Lead Sponsor:
Takeda
Treatments:
Calcium Carbonate Calcium, Dietary Cholecalciferol Ergocalciferols Vitamin D Vitamins